Ignite Creation Date:
2025-12-24 @ 11:00 PM
Ignite Modification Date:
2026-05-27 @ 3:23 AM
Study NCT ID:
NCT00222469
Status:
COMPLETED
Last Update Posted:
2008-07-09
First Post:
2005-09-20
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Combination Chemotherapy for 1st Line Treatment of Advanced or Metastatic Pancreatic Cancer
Sponsor:
University of Oklahoma
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Metastatic Pancreatic Cancer | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | pancreatic cancer | View |
| None | unresectable pancreatic cancer | View |
| None | metastatic pancreatic cancer | View |
| None | bevacizumab | View |
| None | oxaliplatin | View |
| None | gemcitabine | View |
| None | 1st line treatment | View |
| None | first line treatment | View |
| None | locally advanced (unresectable) pancreatic cancer | View |